{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T14:59:44Z","timestamp":1775746784581,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.biologicals.2014.11.005","type":"journal-article","created":{"date-parts":[[2014,12,8]],"date-time":"2014-12-08T23:46:13Z","timestamp":1418082373000},"page":"123-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Development of an intravenous immunoglobulin with improved safety and functional activity"],"prefix":"10.1016","volume":"43","author":[{"given":"Peter L.","family":"Roberts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara","family":"Dolan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martyn","family":"Paddick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirley","family":"Stagg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John E.","family":"More","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2014.11.005_bib1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1423-0410.1999.7740204.x","article-title":"Clinical experience with a new solvent detergent-treated intravenous immunoglobulin free of hypotensive effects","volume":"77","author":"Chidwick","year":"1999","journal-title":"Vox Sang"},{"key":"10.1016\/j.biologicals.2014.11.005_bib2","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1365-2249.2010.04247.x","article-title":"Efficacy and safety of a new immunoglobulin G product, Gammaplex\u00ae, in primary immunodeficiency disease","volume":"162","author":"Moy","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.biologicals.2014.11.005_bib3","volume":"2","author":"Roemisch","year":"2011","journal-title":"Webmed Central Immunotherapy"},{"key":"10.1016\/j.biologicals.2014.11.005_bib4","series-title":"Risk mitigation strategies to address procoagulant activity in immune globulin products","author":"FDA Public workshop","year":"2011"},{"key":"10.1016\/j.biologicals.2014.11.005_bib5","series-title":"Thrombotic potential of IVIGs: clearance of procoagulant activity and product safety","author":"More","year":"2013"},{"key":"10.1016\/j.biologicals.2014.11.005_bib6","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1423-0410.1962.tb03274.x","article-title":"Large scale production of human plasma fractions. Eight years experience with the alcohol fractionation procedure of Nitschmann, Kistler and Lergier","volume":"7","author":"Kistler","year":"1962","journal-title":"Vox Sang"},{"key":"10.1016\/j.biologicals.2014.11.005_bib7","series-title":"Presented at the Eighth International Plasma Product Biotechnology Meeting, Lanzarote","article-title":"Development of a B+I precipitation process model: contribution towards the virus safety of immunoglobulin products","author":"Shackell","year":"2013"},{"key":"10.1016\/j.biologicals.2014.11.005_bib8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/vox.12004","article-title":"Removal of TSE agent from plasma products manufactured in the United Kingdom","volume":"104","author":"Roberts","year":"2013","journal-title":"Vox Sang"},{"key":"10.1016\/j.biologicals.2014.11.005_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0166-0934(99)00135-4","article-title":"Monitoring plasma processing steps with a sensitive Western blot assay for the detection of the prion protein","volume":"84","author":"Lee","year":"2000","journal-title":"J\u00a0Virol Methods"},{"key":"10.1016\/j.biologicals.2014.11.005_bib10","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1172\/JCI102685","article-title":"Studies in intravascular coagulation. I. Coagulation changes in isolated venous segments","volume":"31","author":"Wessler","year":"1952","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.biologicals.2014.11.005_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1423-0410.2002.00186.x","article-title":"A\u00a0direct comparison of the antigen-specific antibody profiles of intravenous immunoglobulin derived from US and UK donor plasma","volume":"83","author":"Matejtschuk","year":"2002","journal-title":"Vox Sang"},{"key":"10.1016\/j.biologicals.2014.11.005_bib12","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0021-9673(01)93998-6","article-title":"Separation of intravenous IgG IVIG containing albumin by high-performance size-exclusion chromatography on TSKGel G3000SWXL","volume":"467","author":"Yamasaki","year":"1989","journal-title":"J\u00a0Chromatogr"},{"key":"10.1016\/j.biologicals.2014.11.005_bib13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1017\/S0022172400053195","article-title":"The use of single-radial-haemolysis for rubella antibody studies","volume":"79","author":"Clarke","year":"1977","journal-title":"J\u00a0Hyg (Lond)"},{"key":"10.1016\/j.biologicals.2014.11.005_bib14","first-page":"147","article-title":"Virus safety of solvent-detergent treated blood products","volume":"81","author":"Horowitz","year":"1993","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.biologicals.2014.11.005_bib15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1423-0410.2011.01502.x","article-title":"Identification of kallikrein and FXIa as impurities in therapeutic immunoglobulins: implications for the safety and control of intravenous blood products","volume":"102","author":"Etscheid","year":"2012","journal-title":"Vox Sang"},{"key":"10.1016\/j.biologicals.2014.11.005_bib16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.biologicals.2012.04.007","article-title":"Virus reduction in an intravenous immunoglobulin by solvent\/detergent treatment, ion-exchange chromatography and terminal low pH incubation","volume":"40","author":"Roberts","year":"2012","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2014.11.005_bib17","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1111\/j.1537-2995.2010.03003.x","article-title":"Contribution to safety of immunoglobulin and albumin from virus partitioning and inactivation by cold ethanol fractionation: a data collection from Plasma Protein Therapeutics Association member companies","volume":"51","author":"Dichtelmuller","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.biologicals.2014.11.005_bib18","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1423-0410.2011.01527.x","article-title":"Widespread distribution of hepatitis E in plasma fractionation pools","volume":"102","author":"Baylis","year":"2012","journal-title":"Vox Sang"},{"key":"10.1016\/j.biologicals.2014.11.005_bib19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00535-012-0682-0","article-title":"Culture systems for hepatitis E virus","volume":"48","author":"Okamoto","year":"2013","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.biologicals.2014.11.005_bib20","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/trf.12050","article-title":"Prion removal capacity of plasma protein manufacturing processes: a data collection from the PPTA member companies","volume":"53","author":"Cai","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.biologicals.2014.11.005_bib21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/vox.12025","article-title":"Thromboembolic events associated with immunoglobulin treatment","volume":"105","author":"Funk","year":"2013","journal-title":"Vox Sang"},{"key":"10.1016\/j.biologicals.2014.11.005_bib22","unstructured":"P&T Product Profiler. Gammaplex\u00ae immune globulin intravenous (Human), 5% liquid. 2011;36:2\u201316."},{"key":"10.1016\/j.biologicals.2014.11.005_bib23","unstructured":"Gammaplex\u00ae product monograph. Hertfordshire, UK: Bio Products Laboratory."}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105614001183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105614001183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T00:22:03Z","timestamp":1538007723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105614001183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1045105614001183"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2014.11.005","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of an intravenous immunoglobulin with improved safety and functional activity","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2014.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}